Views & Analysis Why pharma isn’t yet achieving digital excellence, and how i... Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
